See how a Hyderabad-based Biotech company is saving millions of kids' lives!

Prime Minister Narendra Modi recently launched Rotavirus vaccine Rotavac, developed by Hyderabad-based Bharat Biotech. There are a few things you should know about it!

It is billed as one of the first novel vaccines to be developed completely in the developing world, it is expected to help in significant reduction in infant deaths due to Rotavirus diarrhoea in India and other parts of the world.

Krishna Ella, chairman and managing director of Bharat Biotech, said they realized a dream by bringing out the first made-in-India molecule.

Rotavac is being offered for $1 to governments in low income countries while foreign companies currently sell Rotavirus vaccines in India at Rs.1,100 per dose. The vaccine is affordable, safe and effective, besides being cross-protective against a variety of Rotavirus strains.

The facility in Genome Valley in Hyderabad has an installed manufacturing capacity of 300 million doses per year. It has taken 300 scientists and 15 years for successful for completion of the project, a partnership among the department of biotechnology, Bharat Biotech and several Indian and international organisations.